Who we are
A bright, plain-spoken reading of the ipamorelin literature
Bright, plain-spoken, and cited line by line — with the safety story kept in full view.
What this site is
Script Ipamorelin is a plain-language field guide to the peer-reviewed research on ipamorelin, a selective growth-hormone secretagogue. It is a guide, not a service — no clinic, no pharmacy, no prescriber stands behind it, and it makes, ships, and sells nothing. You will not find dosing here, or diagnosis, or anyone qualified to advise you on your health, because that is simply not what a field guide does. What you will find is a bright, honest map of what the studies actually measured, with every number pinned to its source.
We took a deliberate angle: lead with the safety and tolerability story. Plenty of pages online sell ipamorelin’s upside. Fewer put the failed human trial, the class-level heart signal, and the thin long-term data in plain view next to the reported benefits. That is the job of this guide — make a dense, cautious literature legible without ever tipping into hype.
About the name
The word "script" in this site's name is editorial framing, not a claim about services. "Script" is slang for a prescription — and one of the most useful things this site can tell you plainly is that ipamorelin is not a prescribable, FDA-approved medicine [3]. So the name is a bit of a deliberate counterpoint: people search for ipamorelin as though it's something you get scripted, and a big part of the honest answer is that it isn't. This site occupies the seat of a reader and summarizer of the literature — no clinic, no pharmacy, no prescriber. Nobody here writes, fills, or fulfils a prescription, and nothing on the page is for sale.
How we handle the evidence
Every quantitative claim on this site is tied to a numbered citation in the references, and where a study used a related compound rather than ipamorelin itself, we say so in the text. We keep two things rigorously separate: what controlled studies measured (cited as findings) and what the research-use community reports (clearly labeled anecdotal, not clinical evidence). We don't recommend doses, we don't promise outcomes, and we don't point you toward a place to buy anything. When the evidence runs out — which, for ipamorelin's long-term human safety, it largely does — we say that plainly rather than filling the gap with confidence the literature doesn't support.